News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
369
Sources here
17
Companies here
7
Search results Stored financial headlines

Active search

369 matching headlines

Ticker or company: BOTIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Symbotic (SYM) Is Up 15.3% After Q3 Profit Return And Higher Revenue Outlook - What’s Changed

Symbotic Inc. recently reported third-quarter 2026 results, with revenue rising to US$720.84 million and net income reaching US$11.67 million, alongside the appointment of former Bain Capital Co‑Chair Steve Pagliuca to its Board and new fourth‑quarter revenue guidance of US$760 million to US$780 million. The …

SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -7.6% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics Ltd reports results for the quarter ended June 30 - Earnings Summary

Arbe Robotics Ltd has reported its earnings for the quarter that ended on June 30. The summary of these results is available through Reuters on TradingView, with full access provided through a subscription.

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics earnings beat by $0.02, revenue topped estimates

Arbe Robotics (NASDAQ: ARBE) reported second-quarter earnings per share of $-0.060, exceeding analyst estimates by $0.02. The company's revenue for the quarter was $703K, surpassing the consensus estimate of $631.83K. Despite the earnings beat, Arbe Robotics' stock has seen a decline of -11.860% in …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SYM Q3 Earnings Call Puts Margin Gains and Expansion in Focus

Symbotic Inc. SYM used its fiscal third-quarter 2026 call to emphasize that deployment growth, execution and a broader product set are translating into stronger profitability. Management also provided clearer timing on the next-generation storage architecture, the SymMicro rollout and Exol, while keeping its near-term …

SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -7.6% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics (NASDAQ: ARBE) posts Q2 2026 results, names new CFO

Arbe Robotics reported Q2 2026 revenues of $0.7 million, an increase from $0.3 million in Q2 2025, with a narrowed net loss of $9.1 million compared to $10.2 million a year prior. The company maintained a strong cash position of $41.9 million and reaffirmed …

ARBE main company ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -46.9% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Appoints Assaf Pereg, CPA, as Chief Financial Officer – Company Announcement

Arbe Robotics Ltd. has announced the appointment of Assaf Pereg, CPA, as its new Chief Financial Officer, effective August 30, 2026. Mr. Pereg brings extensive financial leadership experience from various technology companies and will succeed Karine Pinto-Flomenboim. This appointment comes as Arbe transitions from …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics (PRCT) Stock Rises As Revenue Holds Firm And Losses Deepen

PROCEPT BioRobotics (PRCT) stock rose by 5.8% after its Q2 earnings report, despite widening losses. The company reported Q2 sales of US$94.5m and maintained its full-year revenue guidance, indicating sustained growth. However, net losses deepened to US$26.9m, highlighting the company's challenge in balancing revenue …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics Corp 1Q 2026: Revenue $94.5M, EPS ($0.47) — 10-Q Summary

PROCEPT BioRobotics Corp (PRCT) reported its first-quarter 2026 results, showing revenue growth to $94.5 million, an increase of 19.3% year-over-year. Despite the revenue rise, the company recorded a net loss of ($26.86M) and a diluted loss per share of ($0.47), both widening compared to …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings To Watch: Arbe Robotics Ltd (ARBE) Q2 2026 -- GF Value Sees 50% Upside

Arbe Robotics Ltd (ARBE) is preparing to release its Q2 2026 earnings, with consensus estimates predicting $0.5 million in revenue and a loss of $0.08 per share. For the full year 2026, revenue is projected at $4.5 million and a loss of $0.28 per …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Symbotic Inc. (SYM) director Kane sells 2,000 shares, redeems units

Symbotic Inc. director Charles Kane reported a pre-arranged Rule 10b5-1 transaction on August 3, 2026. He redeemed 2,000 Symbotic Holdings Units and corresponding Class V-1 voting shares for 2,000 Class A shares, then sold those shares at $43.21 each, totaling approximately $86,420. After the …

SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -7.6% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Notifies PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors of a Securities Class Action Deadline on September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated reported U.S. handpiece unit …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

[10-Q] PROCEPT BioRobotics Corp Quarterly Earnings Report

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Symbotic Reports Third Quarter Fiscal Year 2026 Results

Symbotic LLC Steve Pagliuca, Former Co-Chair of Bain Capital, Elected to Symbotic's Board of Directors WILMINGTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its third quarter …

SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -7.6% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LFWD Q2'26 Earnings: revenue estimate is 6.53M USD

Lifeward Ltd. (LFWD) is expected to announce its Q2'26 earnings on August 12, with a revenue estimate of $6.53 million and an anticipated EPS of -$1.39. The article provides a detailed table comparing past reported and estimated revenues and EPS, including surprise percentages, for …

LFWD main company
Sharemaestro market context Trend signal active 52 weeks +0.9% · Next-week setup negative 36.3% LFWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access

Lifeward Ltd. has partnered with Ottobock Care to launch a six-month pilot program aimed at increasing U.S. patient access to the ReWalk® 7 Personal Exoskeleton. The initiative will leverage Ottobock Care's extensive clinical expertise and patient care infrastructure across over 50 clinics to raise …

LFWD main company
Sharemaestro market context Trend signal active 52 weeks +0.9% · Next-week setup negative 36.3% LFWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics reports Q2 2026 revenue $94.5M, net loss $26.9M, reiterates FY26 revenue guide

PROCEPT BioRobotics reported Q2 2026 revenue of $94.5 million and a net loss of $26.9 million, while reiterating its full-year 2026 revenue guidance of $390 million to $410 million. The company achieved a 19% year-over-year revenue increase, with U.S. procedures growing by approximately 21% …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Symbotic Inc. (SYM) Misses Q3 Earnings Estimates

Symbotic Inc. (SYM) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -7.6% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Symbotic (SYM) Is Up 8.3% After Earnings Highlight Software-Led Revenue Mix Shift - What's Changed

Symbotic (SYM) saw an 8.3% increase in its stock price after reporting strong quarterly earnings of US$0.12 per share and US$714.76 million in revenue, driven by broad-based growth and an expanding software maintenance and support segment. This performance aligns with the company's investment thesis …

SYM main company SYM main company
Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup negative 34.3% SYM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, marking an earnings surprise of -2.17%. Despite the loss, the company surpassed revenue expectations, posting $94.5 million against an estimated $92.5 …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Are Serve Robotics' (SERV) Growing Robot Fleet And Revenue Guidance Clarify Its Long-Term Profit Path?

Serve Robotics is seeing increased investor interest ahead of its Q2 2026 earnings, driven by its expanding fleet of approximately 2,000 autonomous delivery robots and reaffirmed full-year revenue guidance of about US$26.0 million. While this highlights short-term catalysts, the company still faces the significant …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context